People with type 2 diabetes using insulin and peripheral neuropathy Nutritional, Metabolic, Endocrine Type 2 diabetes
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Age 18-85 years 2. NSS >4/10 and NDS >6/10 3. Blood glucose 4-12 mmol/l before testing 4. Written informed consent
Exclusion criteria
Exclusion criteria: 1. Surgery of stomach or small bowel 2. Opioids, erythromycin, prokinetic agents, L-dopa, ß-agonists, benzodiazepines, ondansetron, tricyclic antidepressives, atropine 3. Eating disorder, portal hypertension, gastric cancer, systemic sclerosis, myotonic dystrophy 4. Pregnancy 5. Implanted cardiac pacemaker/defibrillator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Residence time (min) of the capsule in the stomach measured by 3D-MAGMA | — |
Secondary
| Measure | Time frame |
|---|---|
| 1. Residence time (min) of the capsule in the duodenum measured by 3D-MAGMA 2. Residence time (min) of the capsule in the first 50 cm of the jejunum measured by 3D-MAGMA | — |
Countries
Germany